Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

34.95p
   
  • Change Today:
      0.050p
  • 52 Week High: 71.80
  • 52 Week Low: 34.05
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 237,540
  • Market Cap: £188.87m
  • RiskGrade: 119

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
64.65% below the market average64.65% below the market average64.65% below the market average64.65% below the market average64.65% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
1yr Revenue Growth
27.56% below the market average27.56% below the market average27.56% below the market average27.56% below the market average27.56% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
32.97% above the market average32.97% above the market average32.97% above the market average32.97% above the market average32.97% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
14.24% below the market average14.24% below the market average14.24% below the market average14.24% below the market average14.24% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
30.05% below the market average30.05% below the market average30.05% below the market average30.05% below the market average30.05% below the market average
78.57% below the sector average78.57% below the sector average78.57% below the sector average78.57% below the sector average78.57% below the sector average
Price Book Ratio
52.85% above the market average52.85% above the market average52.85% above the market average52.85% above the market average52.85% above the market average
70.21% above the sector average70.21% above the sector average70.21% above the sector average70.21% above the sector average70.21% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
79.55% below the market average79.55% below the market average79.55% below the market average79.55% below the market average79.55% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Price Chg 3m
48.63% below the market average48.63% below the market average48.63% below the market average48.63% below the market average48.63% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
60.47% below the market average60.47% below the market average60.47% below the market average60.47% below the market average60.47% below the market average
61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average
Momentum 20
62.19% below the market average62.19% below the market average62.19% below the market average62.19% below the market average62.19% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
6.24% below the market average6.24% below the market average6.24% below the market average6.24% below the market average6.24% below the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
ROCE
20.94% above the market average20.94% above the market average20.94% above the market average20.94% above the market average20.94% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
9.04% above the market average9.04% above the market average9.04% above the market average9.04% above the market average9.04% above the market average
65.38% above the sector average65.38% above the sector average65.38% above the sector average65.38% above the sector average65.38% above the sector average
Forecast EPS
65.48% below the market average65.48% below the market average65.48% below the market average65.48% below the market average65.48% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.95% above the market average35.95% above the market average35.95% above the market average35.95% above the market average35.95% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Operating Profit Loss
30.55% above the market average30.55% above the market average30.55% above the market average30.55% above the market average30.55% above the market average
73.08% above the sector average73.08% above the sector average73.08% above the sector average73.08% above the sector average73.08% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
41.64% above the market average41.64% above the market average41.64% above the market average41.64% above the market average41.64% above the market average
56.86% above the sector average56.86% above the sector average56.86% above the sector average56.86% above the sector average56.86% above the sector average
Cash
41.74% above the market average41.74% above the market average41.74% above the market average41.74% above the market average41.74% above the market average
53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average53.85% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
58.71% below the market average58.71% below the market average58.71% below the market average58.71% below the market average58.71% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Buys 1y
1.08% below the market average1.08% below the market average1.08% below the market average1.08% below the market average1.08% below the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
49.05% below the market average49.05% below the market average49.05% below the market average49.05% below the market average49.05% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average
Brokers Percent Neutral
38.16% above the market average38.16% above the market average38.16% above the market average38.16% above the market average38.16% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 34.95p
Change Today 0.050p
% Change 0.14 %
52 Week High 71.80
52 Week Low 34.05
Volume 237,540
Shares Issued 540.40m
Market Cap £188.87m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.29% above the market average84.29% above the market average84.29% above the market average84.29% above the market average84.29% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
70.03% below the market average70.03% below the market average70.03% below the market average70.03% below the market average70.03% below the market average
3.57% above the sector average3.57% above the sector average3.57% above the sector average3.57% above the sector average3.57% above the sector average
Income
11.89% above the market average11.89% above the market average11.89% above the market average11.89% above the market average11.89% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average88.79% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 26-Apr-2024

Time Volume / Share Price
16:35 16,597 @ 34.95p
16:35 485 @ 34.95p
16:35 148 @ 34.95p
16:35 251 @ 34.95p
16:35 148 @ 34.95p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page